Allergan shelling out $750M to settle lawsuit over its Namenda 'hard switch' campaign

28th October 2019 Uncategorised 0

At the price of a $750 million, Allergan has avoided a trial over its effort to force patients onto a newer version of Namenda as the original neared the patent cliff. The drugmaker will pony up to settle allegations that it delayed cheap Namenda generics with its ‘hard switch’ plan, costing purchasers money.

More: Allergan shelling out 0M to settle lawsuit over its Namenda 'hard switch' campaign
Source: fierce